Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 4Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 58Breast 16Gastrointestinal 15Genitourinary 10Head & Neck 8Sarcoma 6Gynecologic 6CNS 6Dermatologic 5Endocrine 2Other solid neoplasm 1NET 1

Conditions

Neuroendocrine Tumors 18von Hippel-Lindau Disease 1Recurrence 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumor Grade 2 1Neuroblastoma 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lung Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoid Tumor 1Adenoma, Islet Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lung Neoplasms × NET × Clear all
NCT02817945 2022-04-07

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNETThoracic

Lung Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡